๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II Radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme

โœ Scribed by Corey J. Langer; James Ruffer; Harker Rhodes; Rebecca Paulus; Kevin Murray; Benjamin Movsas; Walter Curran

Book ID
108434360
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
148 KB
Volume
51
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Final report of a phase I/II trial of hy
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02
โœ Maria Werner-Wasik; Charles B. Scott; Diana F. Nelson; Laurie E. Gaspar; Kevin J ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 825 KB

## BACKGROUND. Efforts to improve local control and survival by increasing the dose of once-daily radiation therapy beyond 70 Gray (Gy) for patients with malignant gliomas have as yet been unsuccessful. Hyperfractionated radiation therapy (HF) should allow for delivery of a higher total dose witho

A Phase I/II study of external beam radi
A Phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207) : Final report
โœ Laurie E. Gaspar; Kathryn Winter; Walter I. Kocha; Lawrence R. Coia; Arnold Hers ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 2 views

## Background: A multiinstitutional, prospective study of the radiation therapy oncology group (rtog) was designed to determine the feasibility and toxicity of chemotherapy, external beam radiation, and esophageal brachytherapy (eb) in a potentially curable group of patients with adenocarcinoma or